2021 Antibacterial agents in clinical and preclinical development: an overview and analysis

Back to the "HIV and Co-Infections News" list
Tags:

The World Health Organization (WHO) released a report evaluating the pipeline of antibacterial candidates in different stages of development and to what extent the present pipeline addresses infections caused by WHO Priority Pathogens, Mycobacterium tuberculosis and Clostridioides difficile.

Read more at Health Policy Watch.

Download ‘2021 Antibacterial agents in clinical and preclinical development: an overview and analysis’ here.

 

For more TB news, check out the latest edition of the TB Online Weekly Newsletter (#22, 30 June 2022).

 

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.